ArticleCellular oncology (Dordrecht, Netherlands)2026

Disrupting CDK9 activity suppresses triple-negative breast cancer and is enhanced by EGFR Inhibition.

Vera E van der Noord et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.